Article
Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and…
bioRxiv · 2021 · Steven Pelech
Key facts
| Title | Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth |
|---|---|
| First author | Steven Pelech |
| Journal | bioRxiv |
| Published | Dec 1, 2021 |
| DOI | 10.1101/2021.11.30.470372 |
| Devices mentioned | K040782, K802418, K973350, K990827, K992252 |
| Product codes mentioned | JAK, JLX, KIS, KQP, LYF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1